Vivani Medical, Inc. - Common Stock VANI 深 沪
等待开盘 12-20 09:30:00 美东时间
1.4295
+0.050
+3.59%
华盛通- 最 高1.45
- 今 开1.36
- 成交量 18.24万股
- 最 低 1.36
- 昨 收 1.38
- 总市值 1.04亿
- 52周最高 1.92
- 市盈率 静 --
- 换手率 0.25%
- 52周最低 0.9054
- 委 比 -50.00%
- 总股本 7295.22万
- 历史最高 576.48
- 量 比 0.87
- 振 幅 6.52%
- 历史最低 0.7536
- 每 手 1
- 风险率 0.18%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Vivani Medical Q3 EPS $(0.11), Inline
Vivani Medical (NASDAQ:VANI) reported quarterly losses of $(0.11) per share which met the analyst consensus estimate. This is unchanged from the same period last year.
11-13 20:47
Vivani Medical Announces Company Presentation, Unveils Obesity Market Strategy With New GLP-1 Implant Technology
https://d1io3yog0oux5.cloudfront.net/_8b0e72ba9731939ad4ef3d445345826e/vivanimedical/db/2227/20875/pdf/Vivani+Corporate+Presentation+_+102925.pdf
11-11 04:19
Vivani Medical Announces $15.7M Stock Offering
The latest update is out from Vivani Medical ( ($VANI) ). On October 26, 2025, ...
10-28 18:28
Vivani Medical完成1600万美元募资
美股周一早盘，生物制药公司Vivani Medical（VANI）股价下跌5.9%，此前该公司宣布以每股1.62美元完成1600万美元募资，所筹资金将用于研...
10-27 22:49
Vivani Medical prices $16M offering at $1.62 per share
Clinical-stage biopharmaceutical company Vivani Medical (NASDAQ:VANI) priced a registered direct offering of 6M shares of its common stock at an offering price of $1.62 per share and concurrent priv...
10-27 15:11
Vivani Medical, Inc. Announces Pricing of Common Stock Offering
Vivani Medical, Inc. announced the pricing of a registered direct offering of 6,000,000 shares and a concurrent private placement of 3,703,703 shares, each at $1.62, raising approximately $15.7 million. Proceeds will support research, clinical development, and working capital. The company focuses on developing ultra-long-acting drug implants for metabolic diseases, aiming to improve patient adherence and tolerance. ThinkEquity acted as the placem...
10-26 23:15
Advani Hotels & Resorts Addresses AGM Proceedings Delay
Advani Hotels & Resorts (India) Ltd. ( ($IN:ADVANIHOTR) ) has shared an upd...
10-04 16:12
Vivani Medical to Present at the Emerging Growth Conference on September 25, 2025
Vivani Medical, Inc. will present at the Emerging Growth Conference 86 on September 25, 2025, at 1:45 pm ET. CEO Adam Mendelsohn will discuss the Company's miniature, ultra-long-acting drug implants for metabolic diseases and respond to pre-submitted questions. The presentation will be available via webcast, with an archived version accessible post-conference. For more details, visit the provided links or contact the company directly. (258 chara...
09-24 13:15
H.C. Wainwright Reaffirms Their Buy Rating on Vivani Medical (VANI)
In a report released yesterday, Yi Chen from H.C. Wainwright reiterated a Buy r...
09-18 16:15
Vivani Sets October 8 Record Date For Spin-Off Of Cortigent, To Trade Under Nasdaq Ticker 'CRGT'
Cortigent is a leading developer of brain implant devices based on precision neurostimulation technology. It is the only company to have obtained FDA approval of a device providing artificial vision for the profoundly blind
09-17 20:35
